|Articles|September 13, 2016

PSI CRO Adopts goBalto Platform

PSI CRO has chosen goBalto’s end-to-end study startup platform for conducting clinical trials from site identification, feasibility and selection through to site activation.

PSI CRO has chosen goBalto’s end-to-end study startup platform for conducting clinical trials from site identification, feasibility and selection through to site activation. PSI CRO will apply the platform for use in a multi-country Phase II Infectious Disease Study.
Read the full release here

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.